Literature DB >> 25355830

Dietary treatment in adults with refractory epilepsy: a review.

Pavel Klein1, Ivana Tyrlikova2, Gregory C Mathews2.   

Abstract

We review adjunctive ketogenic diet (KD) and modified Atkins diet (MAD) treatment of refractory epilepsy in adults. Only a few studies have been published, all open-label. Because of the disparate, uncontrolled nature of the studies, we analyzed all studies individually, without a meta-analysis. Across all studies, 32% of KD-treated and 29% of MAD-treated patients achieved ≥ 50% seizure reduction, including 9% and 5%, respectively, of patients with >90% seizure frequency reduction. The effect persists long term, but, unlike in children, may not outlast treatment. The 3:1 and 4:1 [fat]:[carbohydrate + protein] ratio KD variants and MAD are similarly effective. The anticonvulsant effect occurs quickly with both diets, within days to weeks. Side effects of both diets are benign and similar. The most serious, hyperlipidemia, reverses with treatment discontinuation. The most common, weight loss, may be advantageous in patients with obesity. Potential barriers to large-scale use of both diets in adults include low rate of diet acceptance and high rates of diet discontinuation. The eligible screened/enrolled subject ratios ranged from 2.9 to 7.2. Fifty-one percent of KD-treated and 42% of MAD-treated patients stopped the diet before study completion. Refusal to participate was due to diet restrictiveness and complexity, which may be greater for KD than MAD. However, long-term adherence is low for both diets. Most patients eventually stop the diet because of culinary and social restrictions. For treatment of refractory status epilepticus, only 14 adult cases of KD treatment have been published, providing insufficient data to allow evaluation. In summary, KD and MAD treatment show modest efficacy, although in some patients the effect is remarkable. The diets are well-tolerated, but often discontinued because of their restrictiveness. In patients willing to try dietary treatment, the effect is seen quickly, giving patients the option whether to continue the treatment.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25355830     DOI: 10.1212/WNL.0000000000001004

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Efficacy of a low-carbohydrate or ketogenic diet in preventing patient morbidity and mortality.

Authors:  Roselyn W Clemente Fuentes; Christine M Broszko; Elizabeth S Pietralcyzk; Joan Nashelsky
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

Review 2.  The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors.

Authors:  Roy E Strowd; Stuart A Grossman
Journal:  Curr Treat Options Oncol       Date:  2015-08

Review 3.  Epilepsy and astrocyte energy metabolism.

Authors:  Detlev Boison; Christian Steinhäuser
Journal:  Glia       Date:  2017-10-17       Impact factor: 7.452

Review 4.  Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.

Authors:  Tesfaye W Tefera; Kah Ni Tan; Tanya S McDonald; Karin Borges
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

Review 5.  Systematic review: isocaloric ketogenic dietary regimes for cancer patients.

Authors:  N Erickson; A Boscheri; B Linke; J Huebner
Journal:  Med Oncol       Date:  2017-03-28       Impact factor: 3.064

6.  Ketogenic Diets for Adults With Highly Refractory Epilepsy.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Epilepsy Curr       Date:  2017 Nov-Dec       Impact factor: 7.500

7.  Ketone Bodies as a Possible Adjuvant to Ketogenic Diet in PDHc Deficiency but Not in GLUT1 Deficiency.

Authors:  F Habarou; N Bahi-Buisson; E Lebigot; C Pontoizeau; M T Abi-Warde; A Brassier; K H Le Quan Sang; C Broissand; S Vuillaumier-Barrot; A Roubertie; A Boutron; C Ottolenghi; P de Lonlay
Journal:  JIMD Rep       Date:  2017-05-17

8.  Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.

Authors:  Roy E Strowd; Mackenzie C Cervenka; Bobbie J Henry; Eric H Kossoff; Adam L Hartman; Jaishri O Blakeley
Journal:  Neurooncol Pract       Date:  2015-05-26

9.  Effects of a ketogenic diet on auditory gating in DBA/2 mice: A proof-of-concept study.

Authors:  Jason R Tregellas; Jason Smucny; Kristina T Legget; Karen E Stevens
Journal:  Schizophr Res       Date:  2015-10-09       Impact factor: 4.939

10.  The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit.

Authors:  Brandon A Francis; Jennifer Fillenworth; Philip Gorelick; Kristina Karanec; Adriana Tanner
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.